Do you think the makers of Avastin are worried about the other 4-5 blockbuster drugs in their space? I'm pretty sure their all happy with the $8bill they each individually pull in per year.
Refer to my previous post that multiple vaccination is the way of the future.
I hope both CVac and Abagovomab make it to market.
Our future profit is based on such a minor share of the market.
There is room for plenty of competing vaccines in our space...although realistically it may be limited to 3-4 if it even got to that many.
Early diagnosis tools will also allow multiple vaccines to be used to control, shrink and or eliminate the tumor.
The market is growing: the population, rate of cancer and better diagnosis tools.
Do you think the makers of Avastin are worried about the other...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
-0.013(3.73%) |
Mkt cap ! $468.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.8¢ | 31.5¢ | $1.117M | 3.484M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 244232 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 353265 | 45 |
View Market Depth
| Last trade - 14.54pm 02/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |